Skip to main content
SpringerLink
Log in

The Impact of Housing Temperature-Induced Chronic Stress on Preclinical Mouse Tumor Models and Therapeutic Responses: An Important Role for the Nervous System

  • Chapter
  • First Online:
Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1036))

Abstract

In the last 10–15 years, there has been a recognition that the catecholamines (norepinephrine, NE, and epinephrine, Epi) released by the sympathetic nervous system under stressful conditions promote tumor growth through a variety of mechanisms. Tumors recruit autonomic nerves during their development and NE is then released locally in the tumor microenvironment (TME). Acting through adrenergic receptors present on a variety of cells in the TME, NE and Epi induce proliferation, resistance to apoptosis, epithelial to mesenchymal transition, metastasis of tumor cells, angiogenesis, and inflammation in the TME. These pre-clinical studies have been conducted in mouse models whose care and housing parameters are outlined in “The Guide for the Care and Use of Laboratory Animals [1]. In particular, the Guide mandates that mice be housed at standardized sub-thermoneutral temperatures; however, this causes a state of chronic cold-stress and elevated levels of NE. Although mice are able to maintain a normal body temperature when kept at these cool temperatures, it is becoming clear that this cold-stress is sufficient to activate physiological changes which affect experimental outcomes. We find that when mice are housed under standard, sub-thermoneutral temperatures (~22 °C, ST), tumor growth is significantly greater than when mice are housed at thermoneutrality (~30 °C TT). We also find that the anti-tumor immune response is suppressed at ST and this immunosuppression can be reversed by housing mice at TT or by administration of propranolol (a β-adrenergic receptor antagonist) to mice housed at ST. Furthermore, at ST tumors are more resistant to therapy and can also be sensitized to cytotoxic therapies by housing mice at TT or by treating mice with propranolol. The implications of these observations are particularly relevant to the way in which experiments conducted in preclinical models are interpreted and the findings implemented in the clinic. It may be that the disappointing failure of many new therapies to fulfill their promise in the clinic is related to an incomplete preclinical assessment in mouse models. Further, an expanded understanding of the efficacy of a therapy alone or in combination obtained by testing under a wider range of conditions would better predict how patients, who are under various levels of stress, might respond in a clinical setting. This may be particularly important to consider since we now appreciate that long term outcome of many therapies depends on eliciting an immune response.

It is clear that the outcome of metabolic experiments, immunological investigations and therapeutic efficacy testing in tumors of mice housed at ST is restricted and expanding these experiments to include results obtained at TT may provide us with valuable information that would otherwise be overlooked.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Animals NRCUCftUotGftCaUoL. Guide for the care and use of laboratory animals. 8th ed. Washington, DC: National Academies; 2011.

    Google Scholar 

  2. Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, Frenette PS. Autonomic nerve development contributes to prostate cancer progression. Science. 2013;341(6142):1236361.

    Article  PubMed  Google Scholar 

  3. Szpunar MJ, Belcher EK, Dawes RP, Madden KS. Sympathetic innervation, norepinephrine content, and norepinephrine turnover in orthotopic and spontaneous models of breast cancer. Brain Behav Immun. 2016;53:223–33.

    Article  CAS  PubMed  Google Scholar 

  4. Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol. 1985;135(2 Suppl):755s–65s.

    CAS  PubMed  Google Scholar 

  5. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun. 2007;21(6):736–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Martin B, Ji S, Maudsley S, Mattson MP. “Control” laboratory rodents are metabolically morbid: why it matters. Proc Natl Acad Sci U S A. 2010;107(14):6127–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Feldmann HM, Golozoubova V, Cannon B, Nedergaard J. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab. 2009;9(2):203–9.

    Article  CAS  PubMed  Google Scholar 

  8. Karp CL. Unstressing intemperate models: how cold stress undermines mouse modeling. J Exp Med. 2012;209(6):1069–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lodhi IJ, Semenkovich CF. Why we should put clothes on mice. Cell Metab. 2009;9(2):111–2.

    Article  CAS  PubMed  Google Scholar 

  10. Maloney SK, Fuller A, Mitchell D, Gordon C, Overton JM. Translating animal model research: does it matter that our rodents are cold? Physiology. 2014;29(6):413–20.

    Article  CAS  PubMed  Google Scholar 

  11. Messmer MN, Kokolus KM, Eng JW, Abrams SI, Repasky EA. Mild cold-stress depresses immune responses: implications for cancer models involving laboratory mice. Bioessays. 2014;36(9):884–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Overton J. Phenotyping small animals as models for the human metabolic syndrome: thermoneutrality matters. Int J Obes. 2010;34(Suppl 2):S53–8.

    Article  Google Scholar 

  13. Ravussin Y, LeDuc CA, Watanabe K, Leibel RL. Effects of ambient temperature on adaptive thermogenesis during maintenance of reduced body weight in mice. Am J Physiol Regul Integr Comp Physiol. 2012;303(4):R438–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Xiao C, Goldgof M, Gavrilova O, Reitman ML. Anti-obesity and metabolic efficacy of the beta3-adrenergic agonist, CL316243, in mice at thermoneutrality compared to 22 degrees C. Obesity (Silver Spring). 2015;23(7):1450–9.

    Article  CAS  Google Scholar 

  15. David JM, Chatziioannou AF, Taschereau R, Wang H, Stout DB. The hidden cost of housing practices: using noninvasive imaging to quantify the metabolic demands of chronic cold stress of laboratory mice. Comp Med. 2013;63(5):386–91.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Hylander BL, Repasky EA. Thermoneutrality, mice and cancer: a heated opinion. Trends Cancer. 2016;2(4):166.

    Article  PubMed  Google Scholar 

  17. Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, Thompson EA, Fraser KA, Rosato PC, Filali-Mouhim A, Sekaly RP, Jenkins MK, Vezys V, Haining WN, Jameson SC, Masopust D. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature. 2016;532:512.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gordon CJ. Thermal physiology of laboratory mice: defining thermoneutrality. J Therm Biol. 2012;37:654–85.

    Article  Google Scholar 

  19. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84:277–359.

    Article  CAS  PubMed  Google Scholar 

  20. Cannon B, Nedergaard J. Thermogenesis challenges the adipostat hypothesis for body-weight control. Proc Nutr Soc. 2009;68(4):401–7.

    Article  PubMed  Google Scholar 

  21. Eng JW, Reed CB, Kokolus KM, Pitoniak R, Utley A, Bucsek MJ, Ma WW, Repasky EA, Hylander BL. Housing temperature-induced stress drives therapeutic resistance in murine tumour models through beta-adrenergic receptor activation. Nat Commun. 2015;6:6426.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Golozoubova V, Gullberg H, Matthias A, Cannon B, Vennstrom B, Nedergaard J. Depressed thermogenesis but competent brown adipose tissue recruitment in mice devoid of all hormone-binding thyroid hormone receptors. Mol Endocrinol. 2004;18(2):384–401.

    Article  CAS  PubMed  Google Scholar 

  23. Jhaveri KA, Trammell RA, Toth LA. Effect of environmental temperature on sleep, locomotor activity, core body temperature and immune responses of C57BL/6J mice. Brain Behav Immun. 2007;21(7):975–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kokolus KM, Capitano ML, Lee CT, Eng JW, Waight JD, Hylander BL, Sexton S, Hong CC, Gordon CJ, Abrams SI, Repasky EA. Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature. Proc Natl Acad Sci U S A. 2013;110(50):20176–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Leigh ND, Kokolus KM, O'Neill RE, Du W, Eng JW, Qiu J, Chen GL, McCarthy PL, Farrar JD, Cao X, Repasky EA. Housing temperature-induced stress is suppressing murine graft-versus-host disease through beta2-adrenergic receptor signaling. J Immunol. 2015;195(10):5045–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Povinelli BJ, Kokolus KM, Eng JW, Dougher CW, Curtin L, Capitano ML, Sailsbury-Ruf CT, Repasky EA, Nemeth MJ. Standard sub-thermoneutral caging temperature influences radiosensitivity of hematopoietic stem and progenitor cells. PLoS One. 2015;10(3):e0120078.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Rudaya AY, Steiner AA, Robbins JR, Dragic AS, Romanovsky AA. Thermoregulatory responses to lipopolysaccharide in the mouse: dependence on the dose and ambient temperature. Am J Physiol Regul Integr Comp Physiol. 2005;289(5):R1244–52.

    Article  CAS  PubMed  Google Scholar 

  28. Smith DL Jr, Yang Y, Hu HH, Zhai G, Nagy TR. Measurement of interscapular brown adipose tissue of mice in differentially housed temperatures by chemical-shift-encoded water-fat MRI. J Magn Reson Imaging. 2013;38(6):1425–33.

    Article  PubMed  Google Scholar 

  29. Stemmer K, Kotzbeck P, Zani F, Bauer M, Neff C, Muller TD, Pfluger PT, Seeley RJ, Divanovic S. Thermoneutral housing is a critical factor for immune function and diet-induced obesity in C57BL/6 nude mice. Int J Obes. 2015;39(5):791–7.

    Article  CAS  Google Scholar 

  30. Swoap SJ, Li C, Wess J, Parsons AD, Williams TD, Overton JM. Vagal tone dominates autonomic control of mouse heart rate at thermoneutrality. Am J Physiol Heart Circ Physiol. 2008;294(4):H1581–8.

    Article  CAS  PubMed  Google Scholar 

  31. Swoap SJ, Overton JM, Garber G. Effect of ambient temperature on cardiovascular parameters in rats and mice: a comparative approach. Am J Physiol Regul Integr Comp Physiol. 2004;287(2):R391–6.

    Article  CAS  PubMed  Google Scholar 

  32. Tian Xiao Y, Ganeshan K, Hong C, Nguyen Khoa D, Qiu Y, Kim J, Tangirala Rajendra K, Tonotonoz P, Chawla A. Thermoneutral housing accelerates metabolic inflammation to potentiate atherosclerosis but not insulin resistance. Cell Metab. 2015;23(1):165–78.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Toth LA. The influence of the cage environment on rodent physiology and behavior: implications for reproducibility of pre-clinical rodent research. Exp Neurol. 2015;270:72.

    Article  PubMed  Google Scholar 

  34. Uchida K, Shiuchi T, Inada H, Minokoshi Y, Tominaga M. Metabolic adaptation of mice in a cool environment. Pflugers Arch. 2010;459(5):765–74.

    Article  CAS  PubMed  Google Scholar 

  35. Romanovsky AA, Kulchitsky VA, Simons CT, Sugimoto N. Methodology of fever research: why are polyphasic fevers often thought to be biphasic? Am J Phys. 1998;275(1 Pt 2):R332–8.

    CAS  Google Scholar 

  36. Hasday JD, Fairchild KD, Shanholtz C. The role of fever in the infected host. Microbes Infect. 2000;2(15):1891–904.

    Article  CAS  PubMed  Google Scholar 

  37. Eng JW, Reed CB, Kokolus KM, Repasky EA. Housing temperature influences the pattern of heat shock protein induction in mice following mild whole body hyperthermia. Int J Hyperthermia. 2014;30(8):540–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Bucsek M, Qiao G, MacDonald C, Giridharan T, Evans L, Niedzwecki B, Liu H, Kokolus KM, Eng JW, Messmer MN, Atwood K, Abrams SI, Hylander BL, Repasky EA. β-adrenergic signaling in mouse models housed at standard temperatures suppresses an effector phenotype in CD8+ T cells and undermines checkpoint inhibitor therapy. Cancer Res. 2017.; in press

    Google Scholar 

  39. Ganeshan K, Chawla A. Warming the mouse to model human diseases. Nat Rev Endocrinol. 2017;13(8):458–65.

    Article  PubMed  Google Scholar 

  40. Herrington LP. The heat regulation of small laboratory animals at various environmental temperatures. Am J Physiol. 1940;129:123–39.

    CAS  Google Scholar 

  41. Gordon CJ. Relationship between autonomic and behavioral thermoregulation in the mouse. Physiol Behav. 1985;34(5):687–90.

    Article  CAS  PubMed  Google Scholar 

  42. Gaskill BN, Gordon CJ, Pajor EA, Lucas JR, Davis JK, Garner JP. Heat or insulation: behavioral titration of mouse preference for warmth or access to a nest. PLoS One. 2012;7(3):e32799.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Gaskill BN, Gordon CJ, Pajor EA, Lucas JR, Davis JK, Garner JP. Impact of nesting material on mouse body temperature and physiology. Physiol Behav. 2013;110-111:87–95.

    Article  CAS  PubMed  Google Scholar 

  44. Gilon P, Henquin JC. Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev. 2001;22(5):565–604.

    CAS  PubMed  Google Scholar 

  45. Teramura Y, Terao A, Okada Y, Tomida J, Okamatsu-Ogura Y, Kimura K. Organ-specific changes in norepinephrine turnover against various stress conditions in thermoneutral mice. Jpn J Vet Res. 2014;62(3):117–27.

    PubMed  Google Scholar 

  46. Enerback S, Jacobsson A, Simpson EM, Guerra C, Yamashita H, Harper ME, Kozak LP. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature. 1997;387(6628):90–4.

    Article  CAS  PubMed  Google Scholar 

  47. Liu X, Rossmeisl M, McClaine J, Riachi M, Harper ME, Kozak LP. Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. J Clin Invest. 2003;111(3):399–407.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Anunciado-Koza R, Ukropec J, Koza RA, Kozak LP. Inactivation of UCP1 and the glycerol phosphate cycle synergistically increases energy expenditure to resist diet-induced obesity. J Biol Chem. 2008;283(41):27688–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Kozak LP. Brown fat and the myth of diet-induced thermogenesis. Cell Metab. 2010;11(4):263–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Goldgof M, Xiao C, Chanturiya T, Jou W, Gavrilova O, Reitman ML. The chemical uncoupler 2,4-dinitrophenol (DNP) protects against diet-induced obesity and improves energy homeostasis in mice at thermoneutrality. J Biol Chem. 2014;289(28):19341–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Ravussin Y. Temperature matters with rodent metabolic studies. Obesity (Silver Spring). 2015;23(7):1330.

    Article  Google Scholar 

  52. Jun JC, Shin MK, Yao Q, Devera R, Fonti-Bevans S, Polotsky VY. Thermoneutrality modifies the impact of hypoxia on lipid metabolism. Am J Phys Endocrinol Metab. 2013;304(4):E424–35.

    Article  CAS  Google Scholar 

  53. Koizumi A, Wada Y, Tuskada M, Kayo T, Naruse M, Horiuchi K, Mogi T, Yoshioka M, Sasaki M, Miyamaura Y, Abe T, Ohtomo K, Walford R. A tumor preventive effect of dietary restriction is antagonized by a high housing temperature through deprivation of torpor. Mech Ageing Dev. 1996;92:67–82.

    Article  CAS  PubMed  Google Scholar 

  54. Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol. 2005;5(3):243–51.

    Article  CAS  PubMed  Google Scholar 

  55. Sheridan JF, Dobbs C, Jung J, Chu X, Konstantinos A, Padgett D, Glaser R. Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann N Y Acad Sci. 1998;840:803–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Marino F, Cosentino M. Adrenergic modulation of immune cells: an update. Amino Acids. 2013;45(1):55–71.

    Article  CAS  PubMed  Google Scholar 

  57. Dhabhar FS. Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res. 2014;58(2-3):193–210.

    Article  CAS  PubMed  Google Scholar 

  58. Moragues V, Pinkerton H. Variation in morbidity and mortality of murine typhus infection in mice with changes in the environmental temperature. J Exp Med. 1944;79(1):41–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Underwood GE, Baker CA, Weed SD. Protective effect of elevated temperature on mice infected with Coe virus. J Immunol. 1966;96(6):1006–12.

    CAS  PubMed  Google Scholar 

  60. Wang JF, Meissner A, Malek S, Chen Y, Ke Q, Zhang J, Chu V, Hampton TG, Crumpacker CS, Abelmann WH, Amende I, Morgan JP. Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis. Am J Physiol Heart Circ Physiol. 2005;289(4):H1577–83.

    Article  CAS  PubMed  Google Scholar 

  61. Garcia-Miss Mdel R, Mut-Martin MC, Gongora-Alfaro JL. Beta-adrenergic blockade protects BALB/c mice against infection with a small inoculum of Leishmania mexicana mexicana (LV4). Int Immunopharmacol. 2015;24(1):59–67.

    Article  PubMed  CAS  Google Scholar 

  62. Montazeri M, Daryani A, Ebrahimzadeh M, Ahmadpour E, Sharif M, Sarvi S. Effect of propranolol alone and in combination with Pyrimethamine on acute murine toxoplasmosis. Jundishapur J Microbiol. 2015;8(9):e22572.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Grebe KM, Hickman HD, Irvine KR, Takeda K, Bennink JR, Yewdell JW. Sympathetic nervous system control of anti-influenza CD8+ T cell responses. Proc Natl Acad Sci U S A. 2009;106(13):5300–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Bell JF, Moore GJ. Effects of high ambient temperature on various stages of rabies virus infection in mice. Infect Immun. 1974;10(3):510–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Repasky EA, Evans SS, Dewhirst MW. Temperature matters! And why it should matter to tumor immunologists. Cancer Immunol Res. 2013;1(4):210–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Sen A, Capitano ML, Spernyak JA, Schueckler JT, Thomas S, Singh AK, Evans SS, Hylander BL, Repasky EA. Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models. Cancer Res. 2011;71(11):3872–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Dewhirst MW, Lee CT, Ashcraft KA. The future of biology in driving the field of hyperthermia. Int J Hyperthermia. 2016;32(1):4–13.

    Article  PubMed  Google Scholar 

  68. Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol. 2015;15(6):335–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Padgett DA, Glaser R. How stress influences the immune response. Trends Immunol. 2003;24(8):444–8.

    Article  CAS  PubMed  Google Scholar 

  70. Cole SW, Nagaraja AS, Lutgendorf SK, Green PA, Sood AK. Sympathetic nervous system regulation of the tumour microenvironment. Nat Rev Cancer. 2015;15(9):563–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Cole SW, Sood AK. Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res. 2012;18(5):1201–6.

    Article  CAS  PubMed  Google Scholar 

  72. Eng JW, Kokolus KM, Reed CB, Hylander BL, Ma WW, Repasky EA. A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response. Cancer Immunol Immunother. 2014;63(11):1115–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Melhem-Bertrandt A, Sood AK. Adrenergic signaling and cancer: deciphering the connections. Cancer Biomark. 2013;13(3):131–2.

    Article  PubMed  Google Scholar 

  74. Powe DG, Voss MJ, Zanker KS, Habashy HO, Green AR, Ellis IO, Entschladen F. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget. 2010;1(7):628–38.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: a population- based study. J Clin Oncol. 2011;29(19):2635–44.

    Article  CAS  PubMed  Google Scholar 

  76. Diaz ES, Karlan BY, Li AJ. Impact of beta blockers on epithelial ovarian cancer survival. Gynecol Oncol. 2012;127(2):375–8.

    Article  CAS  PubMed  Google Scholar 

  77. Watkins JL, Thaker PH, Nick AM, Ramondetta LM, Kumar S, Urbauer DL, Matsuo K, Squires KC, Coleman RL, Lutgendorf SK, Ramirez PT, Sood AK. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer. Cancer. 2015;121(19):3444–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. De Giorgi V, Grazzini M, Gandini S, Benemei S, Lotti T, Marchionni N, Geppetti P. Treatment with beta-blockers and reduced disease progression in patients with thick melanoma. Arch Intern Med. 2011;171(8):779–81.

    Article  PubMed  Google Scholar 

  79. Wang HM, Liao ZX, Komaki R, Welsh JW, O'Reilly MS, Chang JY, Zhuang Y, Levy LB, Lu C, Gomez DR. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann Oncol. 2013;24(5):1312–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Grytli HH, Fagerland MW, Fossa SD, Tasken KA. Association between use of beta-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. 2014;65(3):635–41.

    Article  CAS  PubMed  Google Scholar 

  81. Udumyan R, Montgomery S, Fang F, Almroth H, Valdimarsdottir U, Ekbom A, Smedby KE, Fall K. Beta-blocker drug use and survival among patients with pancreatic adenocarcinoma. Cancer Res. 2017;77:3700.

    Article  CAS  PubMed  Google Scholar 

  82. Kim SA, Moon H, Roh JL, Kim SB, Choi SH, Nam SY, Kim SY. Postdiagnostic use of beta-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person-years of follow-up. Clin Transl Oncol. 2017;19:826.

    Article  CAS  PubMed  Google Scholar 

  83. Cardwell CR, Coleman HG, Murray LJ, Entschladen F, Powe DG. Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort. Int J Epidemiol. 2013;42(6):1852–61.

    Article  PubMed  Google Scholar 

  84. Cardwell CR, Coleman HG, Murray LJ, O'Sullivan JM, Powe DG. Beta-blocker usage and prostate cancer survival: a nested case-control study in the UK clinical practice research datalink cohort. Cancer Epidemiol. 2014;38:279.

    Article  PubMed  Google Scholar 

  85. Hicks BM, Murray LJ, Powe DG, Hughes CM, Cardwell CR. Beta-blocker usage and colorectal cancer mortality: a nested case-control study in the UK clinical practice research datalink cohort. Ann Oncol. 2013;24(12):3100–6.

    Article  CAS  PubMed  Google Scholar 

  86. Lutgendorf SK, DeGeest K, Dahmoush L, Farley D, Penedo F, Bender D, Goodheart M, Buekers TE, Mendez L, Krueger G, Clevenger L, Lubaroff DM, Sood AK, Cole SW. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun. 2011;25(2):250–5.

    Article  CAS  PubMed  Google Scholar 

  87. Masur K, Niggemann B, Zanker KS, Entschladen F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res. 2001;61(7):2866–9.

    CAS  PubMed  Google Scholar 

  88. Palm D, Lang K, Niggemann B, Drell TL 4th, Masur K, Zaenker KS, Entschladen F. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer. 2006;118(11):2744–9.

    Article  CAS  PubMed  Google Scholar 

  89. Le CP, Nowell CJ, Kim-Fuchs C, Botteri E, Hiller JG, Ismail H, Pimentel MA, Chai MG, Karnezis T, Rotmensz N, Renne G, Gandini S, Pouton CW, Ferrari D, Moller A, Stacker SA, Sloan EK. Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination. Nat Commun. 2016;7:10634.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Hasegawa H, Saiki I. Psychosocial stress augments tumor development through beta-adrenergic activation in mice. Jpn J Cancer Res. 2002;93(7):729–35.

    Article  CAS  PubMed  Google Scholar 

  91. Al-Wadei HA, Plummer HK 3rd, Ullah MF, Unger B, Brody JR, Schuller HM. Social stress promotes and gamma-aminobutyric acid inhibits tumor growth in mouse models of non-small cell lung cancer. Cancer Prev Res. 2012;5(2):189–96.

    Article  CAS  Google Scholar 

  92. Lin Q, Wang F, Yang R, Zheng X, Gao H, Zhang P. Effect of chronic restraint stress on human colorectal carcinoma growth in mice. PLoS One. 2013;8(4):e61435.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S, Cole SW. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res. 2006;12(2):369–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Creed SJ, Le CP, Hassan M, Pon CK, Albold S, Chan KT, Berginski ME, Huang Z, Bear JE, Lane JR, Halls ML, Ferrari D, Nowell CJ, Sloan EK. Beta2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion. Breast Cancer Res. 2015;17(1):145.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  95. Sood AK, Armaiz-Pena GN, Halder J, Nick AM, Stone RL, Hu W, Carroll AR, Spannuth WA, Deavers MT, Allen JK, Han LY, Kamat AA, Shahzad MM, McIntyre BW, Diaz-Montero CM, Jennings NB, Lin YG, Merritt WM, DeGeest K, Vivas-Mejia PE, Lopez-Berestein G, Schaller MD, Cole SW, Lutgendorf SK. Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J Clin Invest. 2010;120(5):1515–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas BD, Wu L, Sood AK, Cole SW. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70(18):7042–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Nagaraja AS, Dorniak PL, Sadaoui NC, Kang Y, Lin T, Armaiz-Pena G, Wu SY, Rupaimoole R, Allen JK, Gharpure KM, Pradeep S, Zand B, Previs RA, Hansen JM, Ivan C, Rodriguez-Aguayo C, Yang P, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis. Oncogene. 2016;35(18):2390–7.

    Article  CAS  PubMed  Google Scholar 

  98. Park SY, Kang JH, Jeong KJ, Lee J, Han JW, Choi WS, Kim YK, Kang J, Park CG, Lee HY. Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1alpha protein-dependent mechanism. Int J Cancer. 2011;128(10):2306–16.

    Article  CAS  PubMed  Google Scholar 

  99. Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, Barsky SH, Glaser R. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun. 2009;23(2):267–75.

    Article  CAS  PubMed  Google Scholar 

  100. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 2006;66(21):10357–64.

    Article  CAS  PubMed  Google Scholar 

  101. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12(8):939–44.

    Article  CAS  PubMed  Google Scholar 

  102. Sastry KS, Karpova Y, Prokopovich S, Smith AJ, Essau B, Gersappe A, Carson JP, Weber MJ, Register TC, Chen YQ, Penn RB, Kulik G. Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. J Biol Chem. 2007;282(19):14094–100.

    Article  CAS  PubMed  Google Scholar 

  103. Hassan S, Karpova Y, Baiz D, Yancey D, Pullikuth A, Flores A, Register T, Cline JM, D'Agostino R Jr, Danial N, Datta SR, Kulik G. Behavioral stress accelerates prostate cancer development in mice. J Clin Invest. 2013;123(2):874–86.

    CAS  PubMed  PubMed Central  Google Scholar 

  104. Partecke LI, Speerforck S, Kading A, Seubert F, Kuhn S, Lorenz E, Schwandke S, Sendler M, Kessler W, Trung DN, Oswald S, Weiss FU, Mayerle J, Henkel C, Menges P, Beyer K, Lerch MM, Heidecke CD, von Bernstorff W. Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade. Pancreatology. 2016;16(3):423–33.

    Article  CAS  PubMed  Google Scholar 

  105. He D, Manzoni A, Florentin D, Fisher W, Ding Y, Lee M, Ayala G. Biologic effect of neurogenesis in pancreatic cancer. Hum Pathol. 2016;52:182–9.

    Article  CAS  PubMed  Google Scholar 

  106. Pasquier E, Ciccolini J, Carre M, Giacometti S, Fanciullino R, Pouchy C, Montero MP, Serdjebi C, Kavallaris M, Andre N. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget. 2011;2(10):797–809.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Kokolus KM, Spangler HM, Povinelli BJ, Farren MR, Lee KP, Repasky EA. Stressful presentations: mild cold stress in laboratory mice influences phenotype of dendritic cells in naive and tumor-bearing mice. Front Immunol. 2014;5:23.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  108. Wrobel LJ, Bod L, Lengagne R, Kato M, Prevost-Blondel A, Le Gal FA. Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma. Oncotarget. 2016;7:77825–37.

    PubMed Central  Google Scholar 

  109. Elenkov IJ, Chrousos GP. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab. 1999;10(9):359–68.

    Article  CAS  PubMed  Google Scholar 

  110. Elenkov IJ, Chrousos GP. Stress system—organization, physiology and immunoregulation. Neuroimmunomodulation. 2006;13(5-6):257–67.

    Article  CAS  PubMed  Google Scholar 

  111. Panina-Bordignon P, Mazzeo D, Lucia PD, D'Ambrosio D, Lang R, Fabbri L, Self C, Sinigaglia F. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest. 1997;100(6):1513–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA, Street NE. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol. 1997;158(9):4200–10.

    CAS  PubMed  Google Scholar 

  113. Hou N, Zhang X, Zhao L, Zhao X, Li Z, Song T, Huang C. A novel chronic stress-induced shift in the Th1 to Th2 response promotes colon cancer growth. Biochem Biophys Res Commun. 2013;439(4):471–6.

    Article  CAS  PubMed  Google Scholar 

  114. Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, Mukundan L, Brombacher F, Locksley RM, Chawla A. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature. 2011;480(7375):104–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Fischer K, Ruiz HH, Jhun K, Finan B, Oberlin DJ, van der Heide V, Kalinovich AV, Petrovic N, Wolf Y, Clemmensen C, Shin AC, Divanovic S, Brombacher F, Glasmacher E, Keipert S, Jastroch M, Nagler J, Schramm KW, Medrikova D, Collden G, Woods SC, Herzig S, Homann D, Jung S, Nedergaard J, Cannon B, Tschop MH, Muller TD, Buettner C. Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis. Nat Med. 2017;23(5):623–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Guereschi MG, Araujo LP, Maricato JT, Takenaka MC, Nascimento VM, Vivanco BC, Reis VO, Keller AC, Brum PC, Basso AS. Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner. Eur J Immunol. 2013;43(4):1001–12.

    Article  CAS  PubMed  Google Scholar 

  117. Jin J, Wang X, Wang Q, Guo X, Cao J, Zhang X, Zhu T, Zhang D, Wang W, Wang J, Shen B, Gao X, Shi Y, Zhang J. Chronic psychological stress induces the accumulation of myeloid-derived suppressor cells in mice. PLoS One. 2013;8(9):e74497.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Nkontchou G, Aout M, Mahmoudi A, Roulot D, Bourcier V, Grando-Lemaire V, Ganne-Carrie N, Trinchet JC, Vicaut E, Beaugrand M. Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis. Cancer Prev Res. 2012;5(8):1007–14.

    Article  CAS  Google Scholar 

  119. Giampieri R, Scartozzi M, Del Prete M, Faloppi L, Bianconi M, Ridolfi F, Cascinu S. Prognostic value for incidental antihypertensive therapy with beta-blockers in metastatic colorectal cancer. Medicine. 2015;94(24):e719.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Liu J, Blake SJ, Smyth MJ, Teng MW. Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapies. Clin Transl Immunol. 2014;3(8):e22.

    Article  CAS  Google Scholar 

  121. Freedman L, Gibson M. The impact of preclinical irreproducibility on drug development. Clin Pharmacol Ther. 2015;97(1):16–8.

    Article  CAS  PubMed  Google Scholar 

  122. Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov. 2011;10(9):712.

    Article  CAS  PubMed  Google Scholar 

  123. Schein PS, Scheffler B. Barriers to efficient development of cancer therapeutics. Clin Cancer Res. 2006;12(11 Pt 1):3243–8.

    Article  CAS  PubMed  Google Scholar 

  124. Talmadge JE, Singh RK, Fidler IJ, Raz A. Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol. 2007;170(3):793–804.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  125. Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature. 2012;483(7391):531–3.

    Article  CAS  PubMed  Google Scholar 

  126. Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, Finkelstein R, Fisher M, Gendelman HE, Golub RM, Goudreau JL, Gross RA, Gubitz AK, Hesterlee SE, Howells DW, Huguenard J, Kelner K, Koroshetz W, Krainc D, Lazic SE, Levine MS, Macleod MR, McCall JM, Moxley RT 3rd, Narasimhan K, Noble LJ, Perrin S, Porter JD, Steward O, Unger E, Utz U, Silberberg SD. A call for transparent reporting to optimize the predictive value of preclinical research. Nature. 2012;490(7419):187–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Macri S, Ceci C, Altabella L, Canese R, Laviola G. The directive 2010/63/EU on animal experimentation may skew the conclusions of pharmacological and behavioural studies. Sci Rep. 2013;3:2380.

    Article  PubMed  PubMed Central  Google Scholar 

  128. Troublesome variability in mouse studies. Nat Neurosci. 2009;12(9):1075.

    Google Scholar 

  129. Demas GE, Carlton ED. Ecoimmunology for psychoneuroimmunologists: considering context in neuroendocrine-immune-behavior interactions. Brain Behav Immun. 2015;44:9–16.

    Article  CAS  PubMed  Google Scholar 

  130. Lin CS, Lin WS, Lin CL, Kao CH. Carvedilol use is associated with reduced cancer risk: a nationwide population-based cohort study. Int J Cardiol. 2015;184:9–13.

    Article  PubMed  Google Scholar 

  131. Madden KS, Szpunar MJ, Brown EB. Early impact of social isolation and breast tumor progression in mice. Brain Behav Immun. 2013;30(Suppl):S135–41.

    Article  PubMed  Google Scholar 

  132. Li G, Gan Y, Fan Y, Wu Y, Lin H, Song Y, Cai X, Yu X, Pan W, Yao M, Gu J, Tu H. Enriched environment inhibits mouse pancreatic cancer growth and down-regulates the expression of mitochondria-related genes in cancer cells. Sci Rep. 2015;5:7856.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Garofalo S, D'Alessandro G, Chece G, Brau F, Maggi L, Rosa A, Porzia A, Mainiero F, Esposito V, Lauro C, Benigni G, Bernardini G, Santoni A, Limatola C. Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice. Nat Commun. 2015;6:6623.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA

    Bonnie L. Hylander, Jason W.-L. Eng & Elizabeth A. Repasky

Authors
  1. Bonnie L. Hylander
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jason W.-L. Eng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elizabeth A. Repasky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth A. Repasky .

Editor information

Editors and Affiliations

  1. Department of Medicine and Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York, USA

    Pawel Kalinski

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hylander, B.L., Eng, J.WL., Repasky, E.A. (2017). The Impact of Housing Temperature-Induced Chronic Stress on Preclinical Mouse Tumor Models and Therapeutic Responses: An Important Role for the Nervous System. In: Kalinski, P. (eds) Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy. Advances in Experimental Medicine and Biology, vol 1036. Springer, Cham. https://doi.org/10.1007/978-3-319-67577-0_12

Download citation

Publish with us

Policies and ethics

Search

Navigation